Zimmer Biomet (ZBH) Competitors

Zimmer Biomet (NYSE:ZBH) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

Is ZBH or GEHC a better dividend stock?

Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 0.9%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Zimmer Biomet pays out 21.6% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Does the MarketBeat Community prefer ZBH or GEHC?

Zimmer Biomet received 877 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. Likewise, 67.09% of users gave Zimmer Biomet an outperform vote while only 62.22% of users gave GE HealthCare Technologies an outperform vote.

Company	Underperform	Outperform
Zimmer Biomet	Outperform Votes 905 67.09%	Underperform Votes 444 32.91%
GE HealthCare Technologies	Outperform Votes 28 62.22%	Underperform Votes 17 37.78%

Do analysts rate ZBH or GEHC?

Zimmer Biomet presently has a consensus target price of $124.15, suggesting a potential upside of 20.46%. GE HealthCare Technologies has a consensus target price of $94.30, suggesting a potential upside of 34.08%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	2 Sell rating(s)	11 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.32
GE HealthCare Technologies	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

Is ZBH or GEHC more profitable?

Zimmer Biomet has a net margin of 11.77% compared to GE HealthCare Technologies' net margin of 10.13%. GE HealthCare Technologies' return on equity of 25.74% beat Zimmer Biomet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	11.77%	12.99%	7.58%
GE HealthCare Technologies	10.13%	25.74%	6.29%

Which has higher valuation & earnings, ZBH or GEHC?

GE HealthCare Technologies has higher revenue and earnings than Zimmer Biomet. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$7.68B	2.66	$903.70M	$4.45	23.16
GE HealthCare Technologies	$19.67B	1.64	$1.99B	$4.33	16.24

Does the media favor ZBH or GEHC?

In the previous week, GE HealthCare Technologies had 23 more articles in the media than Zimmer Biomet. MarketBeat recorded 39 mentions for GE HealthCare Technologies and 16 mentions for Zimmer Biomet. Zimmer Biomet's average media sentiment score of 1.51 beat GE HealthCare Technologies' score of 0.88 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	15 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
GE HealthCare Technologies	19 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Positive

Which has more volatility and risk, ZBH or GEHC?

Zimmer Biomet has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.

Do insiders & institutionals hold more shares of ZBH or GEHC?

88.9% of Zimmer Biomet shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 1.0% of Zimmer Biomet shares are held by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Zimmer Biomet beats GE HealthCare Technologies on 12 of the 21 factors compared between the two stocks.